The approval is based on the treatment’s late-stage trial results, which showed that Merck’s drug, Zerbaxa, was as effective as another antibacterial drug.
Merck wins U.S. FDA approval for expanded use of antibiotic
More from Industry NewsMore posts in Industry News »
- Sanofi and Translate Bio start clinical trial for mRNA flu vaccine
- Dr Reddy’s Laboratories launches Icosapent Ethyl Capsules in US
- Bharat Biotech’s Covaxin gets SEC approval on its Phase 3 trials efficacy data
- Covid-19 has highlighted the Indian pharma industry’s potential in transforming into an innovation hub: Sudarshan Jain